Schakowsky Pushes For Disclosure Of Drug Research Costs

Although an amendment to require that drug makers disclose what they spend on research was withdrawn before Energy & Commerce members could vote on it, the mere offering of the amendment during the 21st Century Cures markup is a sign to Campaign for Sustainable Rx Pricing President and CEO John Rother that lawmakers aren't satisfied with the lack of information around how much it costs to produce a new drug. A congressional aide, however, said it could be difficult to...